Peconic Partners’s Editas Medicine EDIT Stock Holding History

Peconic Partners’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-148,258	Closed	-$3.56M	–	52
2017 Q3	$3.56M	Buy	+148,258	New	+$2.82M	0.57%	14

Other funds holding EDIT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Peconic Partners's EDIT Position: Q4 2017 in Review

Peconic Partners sold out of Editas Medicine (EDIT) in Q4 2017, closing a stake of 148,258 shares — an estimated $3.56M sold.

Peconic Partners first reported a position in EDIT in Q3 2017 and held it in 1 quarter. The position peaked at $3.56M in Q3 2017. 151 funds tracked by Wall St. Rank hold EDIT as of Q4 2017.

Peconic Partners reported no remaining Editas Medicine position as of Q4 2017 after selling out during the quarter.
Peconic Partners sold 148,258 Editas Medicine shares in Q4 2017, an estimated $3.56M.
Peconic Partners first reported a position in Editas Medicine in Q3 2017 and held it in 1 quarter.
Peconic Partners's Editas Medicine position peaked at $3.56M in Q3 2017.
151 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2017.

Based on Peconic Partners's 13F filing for Q4 2017, filed 14 Feb 2018.